Ravindra Kumar, VP & Chief Scientific Officer at ACCELERON PHARMA INC (XLRN), sold 9,000 shares at $29.85 ($270K) on 2014-08-14, disclosed to the SEC on 2014-08-15.
Scheduled sale ($270k) by VP & Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.85 | 2,000 | $60K | 22.1% |
| 2 | $30.00 | 7,000 | $210K | 77.9% |
| Total | $29.97 avg | 9,000 | $270K | 100% |
| Filing → |
| XLRN | SELL | 2019-01-04 | $249K | — | Filing → |
| XLRN | SELL | 2018-04-04 | $46K | — | Filing → |
| XLRN | SELL | 2018-01-04 | $182K | — | Filing → |